Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice

This study has been completed.

Sponsor:

Information provided by:

Taro Pharmaceuticals USA

ClinicalTrials.gov Identifier:

NCT00244439

First received: October 24, 2005

Last updated: May 4, 2009

Last verified: May 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2006
Primary Completion Date:	October 2006 (Final data collection date for primary outcome measure)